Cargando…
Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases
Herein, we report a case of a 59-year-old man with advanced castration-resistant prostate cancer with rectal invasion. Multimodal treatment, including drug therapy, surgery, and radiation therapy was sequentially performed; however, lymph node metastases repeatedly occurred. Tumor genomic profiling...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460157/ https://www.ncbi.nlm.nih.gov/pubmed/36092022 http://dx.doi.org/10.1016/j.eucr.2022.102210 |
_version_ | 1784786678256238592 |
---|---|
author | Hirayama, Yukiyoshi Kato, Minoru Kimura, Kaoru Otoshi, Taiyo Yamasaki, Takeshi Uchida, Junji |
author_facet | Hirayama, Yukiyoshi Kato, Minoru Kimura, Kaoru Otoshi, Taiyo Yamasaki, Takeshi Uchida, Junji |
author_sort | Hirayama, Yukiyoshi |
collection | PubMed |
description | Herein, we report a case of a 59-year-old man with advanced castration-resistant prostate cancer with rectal invasion. Multimodal treatment, including drug therapy, surgery, and radiation therapy was sequentially performed; however, lymph node metastases repeatedly occurred. Tumor genomic profiling using FoundationOne CDx identified pathogenic alterations in three DNA repair genes, including BRCA2 frameshift mutation. Olaparib, a poly-ADP ribose polymerase inhibitor, showed marked response. Castration-resistant prostate cancer with multiple DNA repair genes was successfully treated with olaparib; comprehensive genome profiling can lead to its optimal clinical management. |
format | Online Article Text |
id | pubmed-9460157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94601572022-09-10 Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases Hirayama, Yukiyoshi Kato, Minoru Kimura, Kaoru Otoshi, Taiyo Yamasaki, Takeshi Uchida, Junji Urol Case Rep Oncology Herein, we report a case of a 59-year-old man with advanced castration-resistant prostate cancer with rectal invasion. Multimodal treatment, including drug therapy, surgery, and radiation therapy was sequentially performed; however, lymph node metastases repeatedly occurred. Tumor genomic profiling using FoundationOne CDx identified pathogenic alterations in three DNA repair genes, including BRCA2 frameshift mutation. Olaparib, a poly-ADP ribose polymerase inhibitor, showed marked response. Castration-resistant prostate cancer with multiple DNA repair genes was successfully treated with olaparib; comprehensive genome profiling can lead to its optimal clinical management. Elsevier 2022-08-30 /pmc/articles/PMC9460157/ /pubmed/36092022 http://dx.doi.org/10.1016/j.eucr.2022.102210 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Oncology Hirayama, Yukiyoshi Kato, Minoru Kimura, Kaoru Otoshi, Taiyo Yamasaki, Takeshi Uchida, Junji Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title | Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title_full | Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title_fullStr | Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title_full_unstemmed | Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title_short | Successful case of olaparib treatment for castration-resistant prostate cancer with multiple DNA repair gene mutations: Use of comprehensive genome profiling for treatment-refractory cases |
title_sort | successful case of olaparib treatment for castration-resistant prostate cancer with multiple dna repair gene mutations: use of comprehensive genome profiling for treatment-refractory cases |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460157/ https://www.ncbi.nlm.nih.gov/pubmed/36092022 http://dx.doi.org/10.1016/j.eucr.2022.102210 |
work_keys_str_mv | AT hirayamayukiyoshi successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases AT katominoru successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases AT kimurakaoru successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases AT otoshitaiyo successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases AT yamasakitakeshi successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases AT uchidajunji successfulcaseofolaparibtreatmentforcastrationresistantprostatecancerwithmultiplednarepairgenemutationsuseofcomprehensivegenomeprofilingfortreatmentrefractorycases |